We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Florfenicol is currently a commonly used veterinary antibiotic; it has a broad antibacterial spectrum and a strong antibacterial effect as well as a low the minimum inhibitory concentration (MIC). The antibacterial of florfenicol is about 15-20 times as high as that of chloramphenicol and thiamphenicol.
After administration through feed for 60 minutes, the drug concentration in the tissue can reach peak, which can quickly control the disease with having characteristics such as being safe, non-toxic, no residue, and no risk for triggering aplastic anemia. Therefore, Florfenicol
is quite suitable for large-scale farms application.
CAS No.:73231-34-2
MF: C12H14Cl2FNO4S
EINECS: 642-986-0
Specification
Item
Specification
Description
White or almost white crystalline powder
Identification
very soluble in N,N-Dimethylformamide, soluble in methanol, sparingly soluble in glacial acetic acid, very slightly soluble in chloroform, Practically insoluble in water
Melting Point
152.0℃ to 156.0℃
Optical Rotation
-16o to -19o
pH
4.5 to 6.5
Chloride
≤0.02%
Fluorine
≥4.8%
Water
≤0.5%
Heavy metals
≤20ppm
Residue on Ignition
≤0.1%
Related substances
1) Peak area of single impurity peak should be NMT the reference solution's main peak 0.5 times (0.5%)
2)Peak area of total impurities shoule be
NMT the peak area of reference solution 2 times (2.0%).
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
